NATURE’S SUNSHINE PRODUCTS, INC. Other Comprehensive Income (Loss), Net of Tax
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Other Comprehensive Income (Loss), Net of Tax of $327.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was $327.00K, a 78.86% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was $185.00K, a 71.80% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was -$1.40M, a 185.66% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was $1.55M, a 509.06% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax for fiscal 2025 was -$896.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax for fiscal 2024 was -$1.32M.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax for fiscal 2023 was -$2.03M.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$3.11M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $327.00K 10-Q · filed 2026-08-06 | $512.00K derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $185.00K 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | -$896.00K 10-K · filed 2026-03-10 | |||
| 2025-09-30 | -$1.40M 10-Q · filed 2025-11-06 | $143.00K derived: sum of 2 quarters · filed 2026-08-06 | $799.00K derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | $1.55M 10-Q · filed 2026-08-06 | $2.20M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $656.00K 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | -$1.32M 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $1.64M 10-Q · filed 2025-11-06 | $1.89M derived: sum of 2 quarters · filed 2025-11-06 | $201.00K derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $254.00K 10-Q · filed 2025-11-06 | -$1.44M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | -$1.69M 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | -$2.03M 10-K · filed 2025-03-11 | |||
| 2023-09-30 | -$593.00K 10-Q · filed 2024-11-07 | -$1.84M derived: sum of 2 quarters · filed 2024-11-07 | -$3.49M derived: sum of 3 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$1.25M 10-Q · filed 2024-11-07 | -$2.90M derived: sum of 2 quarters · filed 2024-11-07 | ||
| 2023-03-31 | -$1.65M 10-Q · filed 2024-11-07 | |||
| 2022-12-31 | -$3.11M 10-K · filed 2024-03-12 | |||
| 2022-09-30 | -$2.54M 10-Q · filed 2023-11-07 | -$5.00M derived: sum of 2 quarters · filed 2023-11-07 | -$5.98M derived: sum of 3 quarters · filed 2023-11-07 | |
| 2022-06-30 | -$2.46M 10-Q · filed 2023-11-07 | -$3.43M derived: sum of 2 quarters · filed 2023-11-07 | ||
| 2022-03-31 | -$975.00K 10-Q · filed 2023-11-07 | |||
| 2021-09-30 | -$925.00K 10-Q · filed 2022-11-03 | -$970.00K derived: sum of 2 quarters · filed 2022-11-03 | -$1.09M derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | -$45.00K 10-Q · filed 2022-11-03 | -$166.00K derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2021-03-31 | -$121.00K 10-Q · filed 2022-11-03 | |||
| 2020-09-30 | $718.00K 10-Q · filed 2021-11-04 | $567.00K derived: sum of 2 quarters · filed 2021-11-04 | $458.00K derived: sum of 3 quarters · filed 2021-11-04 | |
| 2020-06-30 | -$151.00K 10-Q · filed 2021-11-04 | -$260.00K derived: sum of 2 quarters · filed 2021-11-04 | ||
| 2020-03-31 | -$109.00K 10-Q · filed 2021-11-04 | |||
| 2019-09-30 | -$61.00K 10-Q · filed 2020-11-09 | -$591.00K derived: sum of 2 quarters · filed 2020-11-09 | -$907.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | -$530.00K 10-Q · filed 2020-11-09 | -$846.00K 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | -$316.00K 10-Q · filed 2020-11-09 | |||
| 2018-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$254.00K 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | -$266.00K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |